← All Mirum Pharmaceuticals, INC filings

Mirum Pharmaceuticals, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
MIRM
Mirum Pharmaceuticals, INC
DEF: Mirum Pharmaceuticals 2026 Proxy Statement
Mirum Pharmaceuticals has issued its 2026 proxy statement detailing the upcoming annual meeting, director elections, and executive compensation.
NASDAQ
MIRM
Mirum Pharmaceuticals, INC
DEFA14A: Mirum Pharmaceuticals Files Definitive Additional Proxy Materials
Mirum Pharmaceuticals has filed definitive additional materials related to its proxy statement with the SEC.
NASDAQ
MIRM
Mirum Pharmaceuticals, INC
DEF: Mirum Pharmaceuticals Sets Date for 2025 Annual Stockholders Meeting
Mirum Pharmaceuticals will hold its 2025 Annual Meeting of Stockholders on May 29, 2025, to elect directors, ratify the selection of Ernst & Young LLP as the independent registered public accounting firm, and conduct an advisory vote on executive compensation.
NASDAQ
MIRM
Mirum Pharmaceuticals, INC
DEFA14A: Mirum Pharmaceuticals Files Definitive Additional Proxy Materials
Mirum Pharmaceuticals has filed definitive additional materials related to its proxy statement with the SEC.
NASDAQ
MIRM
Mirum Pharmaceuticals, INC
DEF 14A: Mirum Pharmaceuticals Sets Date for 2024 Annual Stockholders Meeting
Mirum Pharmaceuticals will hold its 2024 Annual Meeting of Stockholders on June 5, 2024, in a hybrid format.